Julie T Stratmeyer, OTR | |
311 Mapleton Ave, Boulder, CO 80304-3979 | |
(303) 441-0447 | |
Not Available |
Full Name | Julie T Stratmeyer |
---|---|
Gender | Female |
Speciality | Occupational Therapy |
Experience | 34 Years |
Location | 311 Mapleton Ave, Boulder, Colorado |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073725842 | NPI | - | NPPES |
22 | Other | CO | OTR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
225XH1200X | Occupational Therapist - Hand | (* (Not Available)) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Uchealth Community Services | 5395024905 | 98 |
News Archive
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
Uninsured families are more likely to have medical bill problems, but two-thirds of families with problems paying medical bills—about 13.5 million families—have health insurance coverage, according to findings from HSC's Community Tracking Study 2003 Household Survey, a nationally representative survey involving information on about 25,400 families and 46,600 people.
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, is celebrating a significant milestone.
As more elderly patients undergo the minimally invasive heart valve procedure called Transcatheter Aortic Valve Implantation (TAVR), concerns have been raised as to what causes some to be readmitted for heart failure after the procedure.
Heavy drinking is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, health care and criminal justice expenses.
› Verified 9 days ago
Provider Name | Orthopaedic & Spine Center Of The Rockies Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1770579385 PECOS PAC ID: 0244126365 Enrollment ID: O20040225000914 |
News Archive
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
Uninsured families are more likely to have medical bill problems, but two-thirds of families with problems paying medical bills—about 13.5 million families—have health insurance coverage, according to findings from HSC's Community Tracking Study 2003 Household Survey, a nationally representative survey involving information on about 25,400 families and 46,600 people.
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, is celebrating a significant milestone.
As more elderly patients undergo the minimally invasive heart valve procedure called Transcatheter Aortic Valve Implantation (TAVR), concerns have been raised as to what causes some to be readmitted for heart failure after the procedure.
Heavy drinking is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, health care and criminal justice expenses.
› Verified 9 days ago
Provider Name | Uchealth Community Services |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1841740693 PECOS PAC ID: 5395024905 Enrollment ID: O20161122000429 |
News Archive
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
Uninsured families are more likely to have medical bill problems, but two-thirds of families with problems paying medical bills—about 13.5 million families—have health insurance coverage, according to findings from HSC's Community Tracking Study 2003 Household Survey, a nationally representative survey involving information on about 25,400 families and 46,600 people.
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, is celebrating a significant milestone.
As more elderly patients undergo the minimally invasive heart valve procedure called Transcatheter Aortic Valve Implantation (TAVR), concerns have been raised as to what causes some to be readmitted for heart failure after the procedure.
Heavy drinking is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, health care and criminal justice expenses.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Julie T Stratmeyer, OTR 1604 Oak Dr, Berthoud, CO 80513-1027 Ph: (970) 532-0958 | Julie T Stratmeyer, OTR 311 Mapleton Ave, Boulder, CO 80304-3979 Ph: (303) 441-0447 |
News Archive
As reported recently in the journal Hepatology, WIN-R, a multicenter study of over 5,000 patients with hepatitis C virus (HCV) showed treatment with weight-based REBETOL ribavirin, USP) (RBV) in combination with pegylated interferon (PEG-IFN) alfa-2b achieved significantly higher rates of sustained virologic response (SVR) and lower relapse rates compared to combination therapy using a flat dose of RBV 800 mg/day. Superior response was found particularly in patients with the most difficult-to-treat form of the disease, genotype 1 HCV. Efficacy was consistent across all weight groups.
Uninsured families are more likely to have medical bill problems, but two-thirds of families with problems paying medical bills—about 13.5 million families—have health insurance coverage, according to findings from HSC's Community Tracking Study 2003 Household Survey, a nationally representative survey involving information on about 25,400 families and 46,600 people.
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, is celebrating a significant milestone.
As more elderly patients undergo the minimally invasive heart valve procedure called Transcatheter Aortic Valve Implantation (TAVR), concerns have been raised as to what causes some to be readmitted for heart failure after the procedure.
Heavy drinking is common in the United States and takes a personal and societal toll, with an annual estimated cost of $223.5 billion due to losses in workplace productivity, health care and criminal justice expenses.
› Verified 9 days ago
Kathleen Anne Stumpf, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6500 Arapahoe Rd, Boulder, CO 80303 Phone: 303-447-1010 | |
Dhori Meyer Knud-hansen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1100 Balsam Ave, Boulder, CO 80304 Phone: 303-440-2100 | |
Amalia Beard, MOT, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5412 Idylwild Trl, Boulder, CO 80301 Phone: 303-579-6149 | |
Celia Galvin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6214 Willow Ln, Boulder, CO 80301 Phone: 314-882-4569 | |
Courtney Whalen, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4740 Pearl Pkwy, Boulder, CO 80301 Phone: 303-449-2730 | |
Jakki Ruzich, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3850 Paseo Del Prado St Apt 36, Boulder, CO 80301 Phone: 702-612-7533 | |
David Mangine, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7869 Brockway Dr, Boulder, CO 80303 Phone: 303-888-2819 |